VB

Vasantlal Bhagvanji Kasundra

Active Director Director DIN 07367494
DIN 07367494 First appointment Jan 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2016
Shareholding value •••• Premium profile

About Vasantlal Bhagvanji Kasundra

Data last updated:

Vasantlal Bhagvanji Kasundra is a Director at Fallon Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Fallon Pharmaceuticals Private Limited reported revenue of ₹10.1 Lakh (FY 2019).

DIN 07367494
Primary Designation Director
Industry Pharma
First Appointment 19 Jan 2016
Oldest Company Age 10 yrs
Largest company Fallon Pharmaceuticals Private Limited · ₹10.1 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jan 20162016₹10.1 Lakh (FY 2019)Active

Board colleagues of Vasantlal Bhagvanji Kasundra

Directorship timeline

Open interactive timeline →
Fallon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vasantlal Bhagvanji Kasundra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vasantlal Bhagvanji Kasundra

Vasantlal Bhagvanji Kasundra currently holds 1 directorship: Fallon Pharmaceuticals Private Limited (Director, since 19 Jan 2016, revenue ₹10.1 Lakh (FY 2019)).

Vasantlal Bhagvanji Kasundra was first appointed on 19 Jan 2016 as Director at Fallon Pharmaceuticals Private Limited.

The current boards of Vasantlal Bhagvanji Kasundra's companies include Pavan Bhagawandas Dhanani (Fallon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available